MELAS or m.3243 A>G Mitochondrial DNA Mutation Carrier

Clinical trial pipeline · Data from ClinicalTrials.gov

See which MELAS or m.3243 A>G Mitochondrial DNA Mutation Carrier trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT01532791

Natural History Study - Mitochondrial Disease

Carriers of the m.3242A\>G mutation often have clinical symptoms which can include migraines, seizures, strokes, hearing loss, balance issues, gastrointestinal…

United States300 participantsStarted 2004-07

MELAS or m.3243 A>G Mitochondrial DNA Mutation Carrier

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Natural History Study - Mitochondrial Disease

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Natural History Study - Mitochondrial Disease

All recent trials (1 shown)